Cargando…

Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

BACKGROUND: DNA methyltransferases (DNMTs) are epigenetic enzymes involved in embryonic development, cell differentiation, epithelial to mesenchymal transition, and control of gene expression, whose overexpression or enhanced catalytic activity has been widely reported in cancer initiation and progr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zwergel, Clemens, Schnekenburger, Michael, Sarno, Federica, Battistelli, Cecilia, Manara, Maria Cristina, Stazi, Giulia, Mazzone, Roberta, Fioravanti, Rossella, Gros, Christina, Ausseil, Frédéric, Florean, Cristina, Nebbioso, Angela, Strippoli, Raffaele, Ushijima, Toshikazu, Scotlandi, Katia, Tripodi, Marco, Arimondo, Paola B., Altucci, Lucia, Diederich, Marc, Mai, Antonello, Valente, Sergio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501426/ https://www.ncbi.nlm.nih.gov/pubmed/31060628 http://dx.doi.org/10.1186/s13148-019-0663-8

Ejemplares similares

Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
por: Zwergel, Clemens, et al.
Publicado: (2022)

Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and Degradation
por: Zwergel, Clemens, et al.
Publicado: (2020)

Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
por: Valente, Sergio, et al.
Publicado: (2014)

New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
por: Gros, Christina, et al.
Publicado: (2015)

DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment
por: Sarno, Federica, et al.
Publicado: (2019)

Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells
por: Florean, Cristina, et al.
Publicado: (2016)

Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity
por: Rotili, Dante, et al.
Publicado: (2014)

Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studies
por: Gros, Christina, et al.
Publicado: (2013)

Design, Synthesis and Biological Evaluation of 4-Amino-N-(4-aminophenyl)benzamide Analogues of Quinoline-Based SGI-1027 as Inhibitors of DNA Methylation
por: Rilova, Elodie, et al.
Publicado: (2014)

Synergistic AML Cell Death Induction by Marine Cytotoxin (+)-1(R), 6(S), 1’(R), 6’(S), 11(R), 17(S)-Fistularin-3 and Bcl-2 Inhibitor Venetoclax
por: Florean, Cristina, et al.
Publicado: (2018)

CD99 at the crossroads of physiology and pathology
por: Pasello, Michela, et al.
Publicado: (2018)

CD99: A Cell Surface Protein with an Oncojanus Role in Tumors
por: Manara, Maria Cristina, et al.
Publicado: (2018)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Low-dose DNA demethylating therapy induces reprogramming of diverse cancer-related pathways at the single-cell level
por: Takeshima, Hideyuki, et al.
Publicado: (2020)

Editorial: Molecular Mechanisms and New Therapeutic Targets in Epithelial to Mesenchymal Transition (EMT) and Fibrosis
por: Battistelli, Cecilia, et al.
Publicado: (2020)

Editorial: Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis, volume II
por: Battistelli, Cecilia, et al.
Publicado: (2022)

Restoration of WT1/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells
por: Bontempi, Giulio, et al.
Publicado: (2022)

Selenium-Containing Agents Acting on Cancer—A New Hope?
por: Garbo, Sabrina, et al.
Publicado: (2022)

Epigenetics Offer New Horizons for Colorectal Cancer Prevention
por: Schnekenburger, Michael, et al.
Publicado: (2012)

HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal
por: Rossi, Lucia, et al.
Publicado: (2018)

P1233: TUMOR PREVENTION USING DNA DEMETHYLATING AGENTS ON VIRUS-DERIVED CARCINOGENESIS IN MICE.
por: Yamamoto, Yuta, et al.
Publicado: (2023)

Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas
por: Asano, Naofumi, et al.
Publicado: (2019)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021)

Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis
por: Schnekenburger, Michael, et al.
Publicado: (2014)

3-Chloro-N′-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
por: Sarno, Federica, et al.
Publicado: (2018)

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Trifolium Repens Blocks Proliferation in Chronic Myelogenous Leukemia via the BCR-ABL/STAT5 Pathway
por: Sarno, Federica, et al.
Publicado: (2020)

Sirtuins and Disease: The Road Ahead
por: Carafa, Vincenzo, et al.
Publicado: (2012)

Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype
por: Carafa, Vincenzo, et al.
Publicado: (2019)

Difference in Target Organs in Carcinogenesis with a Heterocyclic Amine, 2‐Amino‐3,4‐dimethylimidazo[4,5‐f]quinoline, in Different Strains of Mice
por: Fujita, Hirofumi, et al.
Publicado: (1999)

Demethylation effect of the antineoplaston AS2-1 on genes in colon cancer cells
por: USHIJIMA, MASATAKA, et al.
Publicado: (2014)

TGFβ Impairs HNF1α Functional Activity in Epithelial-to-Mesenchymal Transition Interfering With the Recruitment of CBP/p300 Acetyltransferases
por: Bisceglia, Francesca, et al.
Publicado: (2019)

Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer
por: Losson, Hélène, et al.
Publicado: (2016)

HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?
por: Losson, Hélène, et al.
Publicado: (2020)

Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy
por: Pinca, Rosa Simona, et al.
Publicado: (2017)

YAP integrates the regulatory Snail/HNF4α circuitry controlling epithelial/hepatocyte differentiation
por: Noce, Valeria, et al.
Publicado: (2019)

Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy
por: Mazzone, Roberta, et al.
Publicado: (2017)

SIRT1 Activation by Natural Phytochemicals: An Overview
por: Iside, Concetta, et al.
Publicado: (2020)

Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy
por: Conte, Mariarosaria, et al.
Publicado: (2020)

Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets
por: Santaniello, Giovanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kac7i272kib4vet8ur1hbpc7d7